The QualityStocks Daily Monday, April 30th, 2018

Today's Top 3 Investment Newsletters

QualityStocks (UNEQ) +88.89%

StockMarketWatch (STDY) +77.36%

NetworkNewsWire (CSRH) +54.76%

The QualityStocks Daily Stock List

Greystone Logistics, Inc. (GLGI)

Trading View, Zacks, and MarketWatch reported on Greystone Logistics, Inc. (GLGI), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Greystone Logistics, Inc. reprocesses and sells recycled plastic, and designs, manufactures, sells, and leases high-quality 100 percent recycled plastic pallets. These provide logistical solutions needed by a broad assortment of industries. These industries include food and beverage, agricultural, automotive, chemical, and pharmaceutical and consumer products.

Greystone Logistics is the largest 100 percent recycled plastic pallet manufacturer in the U.S. A "Green" manufacturing and leasing business, Greystone Logistics is based in Tulsa, Oklahoma. The Company lists on the OTC Markets Group’s OTCQB.

Greystone Logistics provides cost advantages over users of virgin resin. The excess plastic not used in the production of pallets undergoes reprocessing for resale.

Greystone’s products include rackable, nestable, display, monoblock, and stackable pallets. Moreover, the Company’s products include picture frame web-top pallets and web-top pallets. In addition, it sells recycled plastic that undergoes reprocessing into pellet form. Greystone also provides pallet leasing services.

The Company offers recycled pallets for sale including full picture frame and three skids models and IBC pallets. Plastic pallets last 10-50 times longer than wood; have residual (trade-in) value; are recyclable; have a high coefficient of friction with anti-skid design for top, bottom, and fork lift tine contact; have substantially lower life cycle costs (cost per trip), and are suited for closed loop systems. Plastic pallets have no exposed nails, wood chips, or broken boards on manufacturing or warehouse floors.

Greystone Logistics technology, including that used in its injection molding equipment, and its proprietary blend of recycled plastic resins and patented pallet designs, enables speedy production of high-quality pallets and at lower costs than numerous processes. The recycled plastic for its pallets helps control material costs. This is while reducing environmental waste.

In October, Greystone Logistics reported record sales and income for Q1 of fiscal year 2018. Sales for the three months ended August 31, 2017 were $10,287,075 versus $7,844,261 in the prior year ending August 31, 2016. This is an increase of $2,442,814, which represents a 31 percent increase.

Sales to Greystone’s major customers for the quarter ending August 31, 2017, were 73 percent of total sales versus 66 percent in the same period the year prior.

The Company’s net income was $530,282 for the quarter ending August 31, 2017 versus $27,008. Greystone recorded net income attributable to common stockholders for the quarter ending August 31, 2017 of $374,708, or $.01 per share, versus a net loss attributable to common stockholders of $(117,439), or $(0.00) per share in the year ago quarter.

Greystone Logistics, Inc. (GLGI), closed Monday's trading session at $0.40, up 2.56%, on 18,780 volume with 4 trades. The average volume for the last 60 days is 19,968 and the stock's 52-week low/high is $0.29/$0.60.


Canadian Zinc Corporation (CZICF)

Streetwise Reports, Junior Ming Network, Stockhouse, Northern Miner, and Stockwatch reported on Canadian Zinc Corporation (CZICF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Canadian Zinc Corporation is an exploration and development company listed on the OTC Markets’ OTCQB. The Company’s key project is the Prairie Creek Project (100 percent-owned). This is an advanced-stage zinc-lead-silver property positioned in the Northwest Territories. The Prairie Creek Mine has the majority of the required infrastructure in place. Canadian Zinc has its corporate headquarters in Vancouver, British Columbia.

The Company’s long-term objective is to bring the Prairie Creek Mine in the Mackenzie Mountains of the Northwest Territories into production at the earliest possible date.

Canadian Zinc announced in September of 2015 an upgrade to the Mineral Resources at the Prairie Creek Project. Measured and Indicated Resources increased to 8.70 million tonnes averaging 9.5 percent Zn, 8.9 percent Pb and 136 g/t Ag. Inferred Resources remained relatively unchanged at 7.0 million tonnes averaging 11.3 percent Zn, 7.7 percent Pb and 166 g/t Ag.

The Measured and Indicated Resources were subsequently converted into Proven and Probable Reserves measuring 7.6 million tonnes with an average grade of 8.93 percent Zn, 8.33 percent Pb and 127.58 g/t Ag.

In addition, the Company has its Central Newfoundland mineral properties. It acquired two companies with extensive land packages in central Newfoundland considered highly prospective for copper-lead-zinc-silver-gold Volcanogenic Massive Sulphide Deposits.

Canadian Zinc now controls over 500 square kilometers of prospective ground in Central Newfoundland. This includes three polymetallic deposits with NI 43-101 (National Instrument 43-101) compliant resources and numerous early stage exploration targets.

Canadian Zinc's exploration strategy in Newfoundland is to continue to build on its existing polymetallic resource base with the goal of developing either a stand-alone mine, alike to the past-producing mines at Buchans and Duck Pond, or several smaller deposits, which could be developed simultaneously and processed in a central milling facility.

Concerning Prairie Creek, The Prairie Creek Feasibility Study (2017 FS) was completed in September of 2017. The results of the 2017 FS indicate notable improvements versus the Preliminary FS completed in 2016 (2016 PFS).

It confirms that the Prairie Creek Mine can support a substantial increase in the mining rate and mill throughput, which will enable production of higher quantities of zinc, lead and silver, and at lower operating cost versus the mine plan presented in the 2016 PFS.

Canadian Zinc's focus for 2018 is to obtain the financing needed to continue the development of the Prairie Creek Project and advance the Prairie Creek Mine towards production.

Canadian Zinc Corporation (CZICF), closed Monday's trading session at $0.1063, up 11.78%, on 58,040 volume with 11 trades. The average volume for the last 60 days is 32,563 and the stock's 52-week low/high is $0.0893/$0.19.


Avalon Globocare Corp. (AVCO)

InvestorsHub, OTC Markets, and TradingView reported on Avalon Globocare Corp. (AVCO), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Avalon Globocare Corp. provides healthcare services in the United States and China. It operates through its main platforms: Avalon Cell and Avalon Rehabilitation. The Company’s management team draws on their wealth of experience and wide-ranging networks in the biotechnology industry, health care management, and academia. Avalon Globocare lists on the OTC Markets Group’s OTCQB. The Company is headquartered in Freehold, New Jersey.

Avalon Globocare is a first-rate healthcare management provider and biotechnology developer. Its dedication is to integrating and managing global healthcare resources. Furthermore, the Company, via its subsidiary “Avalon RT9 Properties, LLC”, involves in the acquirement and management of healthcare facilities.

The “Avalon Rehabilitation” platform is a turnkey, total suite of rehabilitation services. These services include PT, OT, robotic engineering, cybernectics, and also clinical nutrition. Concerning Avalon Globocare’s healthcare facility, it now includes healthcare property management services, primarily through acquiring and managing healthcare real estate facilities, stem cell banks, and a CAP-certified laboratory that will complement Avalon’s existing platforms.

The Company’s “Avalon Cell” platform centers on cell-based therapies and technologies. Its emphasis is in the field of in vitro diagnostics, regenerative medicine, as well as cancer immunotherapy. Avalon Cell concentrates on transformative and high-impact cell-based bio-technology opportunities in the United States and China. It subsequently fast tracks these to clinical development and commercialization around the world.

Avalon Globocare’s majority-owned subsidiary, GenExosome Technologies, Inc., has acquired 100 percent of the outstanding capital stock of Beijing Jieteng (Beijing GenExosome) Biotech Co. Ltd. Simultaneously, GenExosome entered into and closed an Asset Purchase Agreement with Dr. Yu Zhou, Chief Executive Officer of GenExosome Beijing, where GenExosome acquired all assets, including all intellectual property (IP), patents and patent applications held by Dr. Zhou pertaining to the business of researching, developing, and commercializing exosome technologies.

Last week, Avalon Globocare announced that its subsidiary, GenExosome Technologies, established a joint laboratory for regenerative exosomics with the Shanghai Ninth People's Hospital (SNPH). The joint laboratory will use Avalon Globocare's proprietary exosome isolation system to expedite the development of diagnostic and therapeutic applications utilizing stem cell-derived exosomes.

With this agreement, Avalon will own the exclusive rights for development and commercialization of products derived from the joint laboratory. All IP developed via the partnership will be jointly owned by Avalon Globocare and SNPH. SNPH is a top-ranked medical institute in China and the Asia Pacific region, renowned for its plastic and reconstructive surgery specialty.

Avalon Globocare Corp. (AVCO), closed Monday's trading session at $1.95, up 2.09%, on 1,500 volume with 2 trades. The average volume for the last 60 days is 10,191 and the stock's 52-week low/high is $0.51/$4.60.


Helix TCS, Inc. (HLIX)

The Stock Rover, The Daly Marijuana Observer, Marketwired, Simply Wall St, Business Insider, Market Exclusive, GreenMarketReport, Stock Daily Review, and The Street reported on Helix TCS, Inc. (HLIX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Helix TCS, Inc. is a provider of integrated operating environment solutions for the legal cannabis Industry. The Company has acquired Cannabase, which is the oldest and largest wholesale platform in the cannabis industry. Helix TCS’ corporate mission is to provide clients with the most powerful and innovative integrated operating environments in the market. This is to help clients better manage and reduce risk while they focus on their core business.

Helix TCS has its headquarters in Greenwood Village, Colorado. In early April, Helix TCS reported record Revenues for 2017. For the fiscal year ending December 31, 2017, the Company produced record Revenues of $4,029,800. This represents 90 percent growth over 2016 Revenues of $2,121,600.

Helix TCS’ team comprises former military, law enforcement, and technology professionals. The Company’s services include Technology, Compliance, and Security. It offers a technology platform that permits clients to manage inventory and supply costs through Cannabase.

Regarding Security, Helix TCS offers Transport, Armed and Unarmed Guarding, Training, Investigation, and also Special Services. Security is the Company’s flagship service offering.

Pertaining to Compliance, the Company has a broad array of compliance services for companies in the Cannabis Industry. This safeguards clients’ ability to operate while increasing their access to services.

Helix TCS announced its acquisition of Security Grade Protective Services, Ltd in June of last year.  Security Grade now operates as a wholly-owned subsidiary of Helix TCS. Security Grade is a Denver, Colorado-based security firm. It provides a range of custom, full-service security solutions to cannabis business customers.

In March, Helix TCS announced that it signed a merger agreement with Bio-Tech Medical Software, Inc. (dba BioTrackTHC).  The combined company will trade under the Helix stock symbol, HLIX, on the OTCQB.  Both companies will continue to operate independently. However, they will consolidate common business functions. Mr. Patrick Vo will continue as Chief Executive Officer (CEO) of BioTrack. Mr. Zachary L. Venegas will continue as the CEO of Helix, with the additional duty as the Board Executive Chairman.

Bio-Tech Medical Software, via its BioTrackTHC division, develops and licenses product traceability, inventory management, and point-of-sale (POS) software systems for the developing medical and recreational cannabis industry.

Last week, The Commonwealth of Puerto Rico in harmonization with the Department of Health's seed-to-sale traceability provider, BioTrackTHC, officially deployed its government seed-to-sale Traceability System to supervise the island's medical cannabis industry. This system will enable the government to track and regulate the medical cannabis supply chain, product safety, as well as sales.

Helix TCS, Inc. (HLIX), closed Monday's trading session at $1.40, down 6.67%, on 17,349 volume with 48 trades. The average volume for the last 60 days is 23,168 and the stock's 52-week low/high is $0.75/$6.25.


Centamin Plc (CELTF)

MarketWatch, Zacks, Morningstar, YCharts, Stockhouse, InvestorsHub, Amigobulls, The Street, Barchart, and Marketbeat reported on Centamin Plc (CELTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Centamin Plc, together with its subsidiaries, engages in the exploration, mining, and development of precious metals. The Company’s main asset is the Sukari Gold Mine (Production Project). It commenced production in 2009 and is the first large scale modern gold mine in Egypt. Centamin’s most advanced Exploration Projects are in highly prospective regions within the investor-friendly jurisdictions of Burkina Faso and Cote d'Ivoire.

Centamin has its corporate office in St Helier, the Channel Islands. The Company also has offices in Alexandria, Egypt, and Mount Pleasant, Western Australia.

Base case production is c. 500,000 ounces per annum at the Sukari Gold Mine. The Company states that there is the potential to surpass this level as optimization of the mining and processing operations continues.

With the completion of the Stage 4 expansion project in 2014, the Sukari operation transitioned out of its investment phase and into a sustainable period of free cash flow generation over the remaining life of mine. Centamin states that cash flows are set to grow further over the coming years as production continues to grow and costs decrease. There is no further need for substantial expansion capital. Therefore, the operation is well positioned to benefit from a recovery in the gold price.

At Sukari, Ore is provided from two mining operations: a large-scale open pit that provides about 90 percent of the ore feed, with the balance from a higher-grade underground mine. The Sukari Gold Mine has a large reserve and resource base. Moreover, there is further exploration upside in Sukari hill and on the 160km2 tenement area that surrounds it.

At June 30, 2015, the total Measured and Indicated resource was 13 million ounces (Moz) gold. It is reported as an open pit resource at 0.3g/t cut-off grade. This total is inclusive of the 1.0 Moz underground resource.

Regarding Exploration Projects, Centamin completed its recommended all-share takeover offer for ASX-listed Ampella Mining Ltd on February 24., 2014. As a result, the Company gained control of an extensive license holding over a highly prospective and underexplored 100km-plus trend of gold mineralization in Burkina Faso, and more exploration properties across the border in Côte d'Ivoire.

Centamin has four permits in Cote d’Ivoire encompassing a circa 1,517km2 area across the border from Batie West in Burkina Faso.

Centamin Plc (CELTF), closed Monday's trading session at $2.174, up 3.52%, on 15,000 volume with 9 trades. The average volume for the last 60 days is 6,888 and the stock's 52-week low/high is $1.704/$2.30. 


Progressive Care, Inc. (RXMD)

OTC Markets and Investors Hangout reported on Progressive Care, Inc. (RXMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Progressive Care, Inc., via its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization. The Company is moving ahead in its work to grow the Company by expanding its facility, adding new locations, acquiring operating pharmacies, and further developing its present business lines. Progressive Care has its corporate headquarters in North Miami Beach, Florida.

The Company is a provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities. It is also a provider of administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, as well as health practice risk management.

Progressive Care owns PharmCo LLC. PharmCo formed in 2005 as a Florida Limited Liability Corporation with the aim of becoming a first-class pharmacy in the South Florida community. PharmCo has developed into a health services company that centers on the provision of prescription pharmaceuticals.

PharmCo’s compounding department specializes in formularies such as non-narcotic topical pain creams, wound care creams, scar gels, and hormone replacement therapies. In addition, it offers EnovaRx, which are Food and Drug Administration (FDA) approved manufactured pain creams. These are promptly available with a prescription.

Furthermore PharmCo prepares psoriasis creams, wellness vitamins, weight loss formulations and holistic capsules that are 100 percent Kosher and Halal certified. PharmCo has attained much of its growth by way of targeted marketing to new doctors' offices and clinics.

Progressive Care opened Smart Medical Alliance, Inc. on September 1, 2016. It opened Smart Medical to assist healthcare providers with navigating the complex risk management environment of their insurance network contracts.

Smart Medical Alliance provides management and support services to doctors and administrators under capitated and fee-for-services insurance contracts. Smart Medical Alliance is the premier Outsourced Clinical and Management Services Partner.

Last month, Progressive Care announced greater than $1.7 million in net revenues on more than 21,000 prescriptions filled in October 2017. Prescriptions filled increased by close to 15 percent over the same month the year prior and by 5 percent over the last record setting month in August of 2016. This is a 24 percent increase over September 2017.

Moreover, Progressive Care announced last week more than $1.7 million in net revenues on close to 21,000 prescriptions filled in November 2017. Prescriptions filled increased by almost 13 percent over the same month the year prior. Additionally, the Company filled more than $400,000 worth of prescriptions for 340B entities, generating fees to the pharmacy of just over $17,000.

Progressive Care, Inc. (RXMD), closed Monday's trading session at $0.0865, up 8.12%, on 3,864,043 volume with 198 trades. The average volume for the last 60 days is 11,667,299 and the stock's 52-week low/high is $0.01/$0.2659.


Sayona Mining Limited (DMNXF)

4-Traders, Stockwatch, MarketWatch, Stockhouse, Capital Equity Review, InvestorsHub, OilandGas 360, The Street, Barchart, Your Drilling News, CentralCharts, OTC Markets, Penny Stock Hub, WalletInvestor, HotCopper, Metals News, Investors Hangout, Penny Stock Tweets, and Predict Wall Street reported on Sayona Mining Limited (DMNXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sayona Mining Limited, together with its subsidiaries, engages in the identification, acquisition, evaluation, and exploration of mineral assets in Australia and around the world. It mainly explores for lithium and graphite. The Company previously went by the name DiamonEx Limited. It changed its name to Sayona Mining Limited in May of 2013. Headquartered in Paddington, Australia, Sayona Mining lists on the OTC Markets.

The Company’s emphasis is on sourcing and developing the raw materials needed to make lithium-ion batteries. Sayona Mining’s chief focus is the development of the advanced stage Authier Lithium Project in the Province Quebec. The Authier Project is 45 kilometers northwest of the city of Val d’Or, a major mining service center in Quebec. Authier mineralization is hosted in a spodumene-bearing pegmatite intrusion with greater than 18,000 meters of drilling in 139 holes.

The Authier Lithium Project is amenable to simple open-cut mining and processing methods. This project is in close proximity to development infrastructure. In July of 2016, the Company acquired 100 percent of the Authier project for CAD$4 million. Sayona Mining also controls a portfolio of lithium and graphite exploration projects in Western Australia.

The Authier Lithium Project has advanced, near term development potential. It has a Pre-Feasibility Study (PFS) demonstrating technical and economic viability. The Project area consists of 19 mineral claims totaling 653 hectares, and extends 3.4 kilometers in an east-west, and 3.1 kilometers in a north-south direction, respectively. The location of the Mineral claims is over Crown Land.

The Authier Lithium Project was initially drilled between 1991 and 1999, and subsequently by Glen Eagle between 2010 and 2012. Sayona Mining completed over 8,000 meters of drilling during 2016 and 2017.

Regarding Western Australia, Sayona Mining has 17 tenements in the Pilbara Region, encompassing a total area of 1918km2. Of these, 9 were acquired via a deal with Great Sandy, with the Mallina Project – E47/2983, being the flagship project.

The East Kimberley Graphite Project is Sayona Mining’s strategic entry into the graphite market. It announced in 2015 a strategic entry into the large flake graphite market through securing a large ground position in the East Kimberley region of Western Australia. The Kimberley region is a proven province for high purity, large flake graphite.

The East Kimberley project is 240 kilometers south of Wyndham Port and 220 kilometers south-south-west of the regional center, Kununurra. The Project includes one granted tenement and three separate tenement applications. The Project encompasses 278 km2. It consists of two areas, Keller and Corkwood. Sayona Mining has 100 percent of the graphite interests across 4 tenements in the East Kimberley, following the completion of 2 option-to-purchase agreements.

Sayona Mining Limited (DMNXF), closed Monday's trading session at $0.042, down 4.55%, on 28,100 volume with 3 trades. The average volume for the last 60 days is 454,402 and the stock's 52-week low/high is $0.005/$0.10.


Golden Predator Mining Corp. (NTGSF)

Junior Mining Network, Barchart, OTC Markets, Stockhouse, Gold Investment Letter, Penny Stock Hub, and The Street reported on Golden Predator Mining Corp. (NTGSF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets, Golden Predator Mining Corp. acquires and explores for mineral properties in the United States and Canada. The Company focuses on its district scale, orogenic gold-in-quartz 3 Aces Project in the Yukon. Incorporated in 2008, the Company formerly went by the name Northern Tiger Resources, Inc. It changed its corporate name to Golden Predator Mining Corp. in April 2014. Golden Predator Mining is headquartered in Vancouver, British Columbia.

The 100 percent owned 3 Aces Project is 357 km2 (35,700 hectares). It is a high-grade gold project (Orogenic Gold Model). The 3 Aces Project includes at least 6 mineralized areas. These are all situated within and along favorable stratigraphic and structural zones that extend greater than 35km along trend.

Several mineralized veins have been discovered so far. Many have visible gold occurrences. The 3 Aces Project hosts the two highest grade surface outcrops discovered to date in the Yukon.

The initial focus of the 2018 exploration program will be to drill wide-spaced diamond core holes into the major shear zones and folds associated with the postulated anticline. This work will begin in the Central Core Area and move along strike and down dip following already identified gold-bearing structures.

Golden Predator Mining also holds 100 percent of the advanced Brewery Creek Project in the Yukon. The Brewery Creek Mine is operated by Golden Predator Mining Corp.

The target at the Brewery Creek Mine is an intrusion related gold deposit. Gold is the commodity at Brewery Creek. The Brewery Creek Mine is 55km east of Dawson in the northwestern region of the Yukon.

The Company reported this past January the results of 42 Reverse Circulation (RC) drill holes completed in 2017 at the 3 Aces Project. Initial drilling is reported from the Diamonds Zone along with the Hearts/Clubs Corridor. Golden Predator Mining stated that all areas encountered encouraging results and will see continued drilling in 2018.

The Company also reported in January the results of 43 Grade Control drill holes at the 3 Aces Project. This includes the highest gold assays returned to date from drilling on this project.

The design of the drill holes was to investigate close-space variability in three different areas of the Spades Zone. This is to prepare for resource delineation drilling across the Central Core Area later this year.

In March, Golden Predator Mining announced that it started a 4,000 meter (m) diamond drill program at the 3 Aces Project in southeastern Yukon. This drill program will first concentrate on stepping-out with wide-spaced drilling within the Central Core Area, testing continuity along favorable stratigraphic-structural contacts along the Hearts-Clubs corridor and from the Spades area, now believed to represent the down dip extension of the Hearts-Clubs corridor.

Results from 2017 drilling along the Hearts-Club Corridor include 19.81m of 3.32 g/t gold from a depth of 10.67m (3A17-203), and 4.57 m of 81.35 g/t gold from a depth of 0.76 m (3A17-208) at Spades.

Golden Predator Mining Corp. (NTGSF), closed Monday's trading session at $0.33, down 5.71%, on 125,576 volume with 32 trades. The average volume for the last 60 days is 76,740 and the stock's 52-week low/high is $0.32/$1.1815.


Humanigen, Inc. (HGEN)

AmigoBulls, Barchart, TradingView, Investopedia, InvestorsHub, OTC Markets, Investors Hangout, and Financial Times reported on Humanigen, Inc. (HGEN), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

A biopharmaceutical company, Humanigen, Inc. focuses on advancing medicines for patients with neglected and rare diseases by way of unique, accelerated business models. Lead compounds in the Company’s portfolio include benznidazole, and the proprietary monoclonal antibodies, lenzilumab and ifabotuzumab. OTCQB-listed, Humanigen is based in Brisbane, California.

Humanigen pursues innovative science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments. Benznidazole is for the potential treatment of Chagas disease in the U.S. Chagas disease is a parasitic infection caused by a protozoan organism named Trypanosoma cruzi, which affects millions of people primarily in rural areas of Mexico, Central and South America.

Lenzilumab has potential for treatment of various rare diseases. This includes hematologic cancers such as chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML).

Lenzilumab is a Humaneered® recombinant monoclonal antibody. It neutralizes soluble granulocyte-macrophage colony-stimulating factor (GM-CSF), which is a critical cytokine that propels the growth of certain hematologic malignancies.

Ifabotuzumab is a first-in-class, monoclonal antibody. It targets the EphA3 receptor tyrosine kinase created using Humanigen's proprietary Humaneered® technology.

Humanigen announced in August 2017 that it completed enrolment and follow-up of subjects in its human bioavailability study for benznidazole. The bioavailability study is an important part of its planned New Drug Application (NDA) package to the U.S. Food and Drug Administration (FDA) in the 505(b)(2) development program for benznidazole as a potential treatment for Chagas disease. The study’s principal objective is to characterize the pharmacokinetic profile of benznidazole.

Humanigen continues to enrol patients in its Phase 1 study of lenzilumab for the treatment of chronic myelomonocytic leukemia (CMML), a rare hematologic cancer. Interim data is expected in the first half of 2018.

The other key asset in the Company’s monoclonal antibody portfolio, ifabotuzumab, has been dosed in the first patient in an investigator-sponsored phase 0/1 radio-labeled imaging trial in glioblastoma multiforme (GBM). GBM is a particularly aggressive and deadly brain cancer.

Yesterday, Humanigen announced it entered into definitive agreements with its lenders to, among other things, exchange the entire balance of roughly $16.3 million in term loans for common stock of Humanigen. The expectation is that the transactions will close in Q1 2018 subject to the satisfaction of certain conditions contained in the definitive agreements.

In addition, the Company will receive a new $3 million investment from an affiliate of Black Horse Capital, one of the lenders, to fund the Company and its transformational new strategy of developing the monoclonal antibodies lenzilumab and ifabotuzumab in the fast-growing areas of immunotherapy and oncology.

Humanigen, Inc. (HGEN), closed Monday's trading session at $0.46, up 2.22%, on 800 volume with 3 trades. The average volume for the last 60 days is 9,222 and the stock's 52-week low/high is $0.125/$2.95.


InterCloud Systems, Inc. (ICLD)

Broad Street, StocksImpossible, OTCBB Journal, Stock Onion, Stock Tips Network, Buzz Stocks, Greenbackers, Jason Bond, RedChip, Wealthpire Inc., PennyStockProphet, Penny Pick Finders, Market Report, BUYINS.NET, GreatStockPix, Street Insider, Microcapmillionaires, PennyPro, Promotion Stock Secrets,, Planet Penny Stocks, Hit and Run Candle Sticks, and Investing Futures reported earlier on InterCloud Systems, Inc. (ICLD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

InterCloud Systems, Inc. is a foremost provider of cloud networking orchestration and automation solutions and services. It provides contemporary Information Technology (IT) and network solutions to the enterprise markets by way of cloud computing and professional services. InterCloud provides cloud services (SaaS, PaaS, and IaaS), professional consulting, data solutions, as well as maintenance services.

InterCloud Systems’ business mission is to enable carriers to speed up the installment of Virtualized Network and IT Services. Formed in 2006, the Company is headquartered in Shrewsbury, New Jersey. InterCloud Systems has its software platform.

InterCloud Systems is a leading provider of cloud networking orchestration and automation for Software Defined Networking (SDN) and Network Function Virtualization (NFV) cloud environments. It is a provider to the telecommunications service provider (carrier) and corporate enterprise markets.

The Company’s cloud solutions provide enterprise and service-provider customers the opportunity to adopt an operational expense model through outsourcing cloud deployment and management to InterCloud Systems.

InterCloud’s products and solutions include NFVGrid – NFVO Management & Analytics Platform. This is a full scale next generation networking platform for virtualized network functions. NFVGrid is proprietary IP. Nonetheless NFVGrid totally embraces Open Source.

The Company’s solutions include Disaster Recovery. Its cloud backup allows one to backup their important business data to a remote and secure location for fast disaster recovery.

Concerning its Professional Services, InterCloud Systems has a 24×7 practice for manifold technologies. These include Unix/Linux System Administration; Microsoft System Administration; VMware Administration; and Open Stack/Cloud Stack. These also include Juniper Design, Operate & Support; Cisco Design, Operate & Support; and Citrix Design, Operate & Support. In March of this year, InterCloud Systems announced the Closing on the sale of ADEX Corporation. Under the terms of the asset sale, the Company will receive $5 Million in a combination of cash and seller’s note. Recently, InterCloud Systems announced it signed a significant license agreement with a Voice Over IP (VOIP) carrier.

Mr. Mark Munro, InterCloud Systems’ Chief Executive Officer, stated, “The signing of this agreement is an incredibly important milestone. Our SD-WAN team has worked diligently to create a software platform that can be integrated and customized to meet the needs of Tier 2 and Tier 3 carriers today. The years of investment and development have paid off as is poised for growth and market acknowledgement. Our goal is to stay focused and build upon this momentum throughout 2018…”

InterCloud Systems, Inc. (ICLD), closed Monday's trading session at $0.0743, up 3.05%, on 212,151 volume with 31 trades. The average volume for the last 60 days is 225,572 and the stock's 52-week low/high is $0.0605/$19.56.


Biotricity, Inc. (BTCY)

Stock News Now, SmallCap Network, and SECFilings News reported earlier on Biotricity, Inc. (BTCY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Biotricity, Inc. is a medical diagnostic and consumer healthcare technology company based in Redwood City, California. Its dedication is to deliver biometric remote monitoring solutions. The Company delivers these solutions to the medical and consumer markets. This includes diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement.

Biotricity’s vision is putting health management into the hands of the individual. The Company is working to support the self-management of critical and chronic conditions with the use of inventive solutions to ease the increasing burden on the healthcare system. Biotricity’s Research and Development (R&D) continues to focus on the preventative healthcare market.

The Company has created two ECG monitoring devices. The design of these is to improve upon the tools and devices available in today’s market. For Consumers, Biotricity has its Biolife. This is a preventative care solution. It takes advantage of the expertise gained from the Company’s Bioflux.

The design of Biolife is to assist individuals in tracking their progress in real-time so they can stay motivated to make lifestyle changes. Biolife helps users make lifestyle changes through uniting medically relevant ECG data with social media interactivity and a lifestyle log.

For Physicians, Biotricity has its Bioflux. This is a medical technology solution for physicians to test and diagnose patients, and benefit from a unique system that provides continuing active monitoring for up to 30 consecutive days.

Bioflux consists of an ECG monitoring device, software, and also access to a monitoring lab. The Bioflux software component is an acquisition that is already Food and Drug Administration (FDA) cleared. It is a standard for ECG monitoring in hospitals and cardiac clinics.

Biotricity has partnered with Global to Local (G2L). This collaboration between Biotricity and G2L will initially concentrate on building distinct solutions for outcome measurements for individuals suffering from chronic disease.

G2L is an organization committed to providing programs that improve individual and community health outcomes, expands access to healthcare services, and empowers economic development in the most diverse and underserved communities.

In 2017, Biotricity’s milestones included achieving 510(k) clearance for Bioflux 1.0. The Company also closed a registered direct offering with existing shareholders. Furthermore, it started extending the capabilities of its remote patient monitoring (RPM) platform with artificial intelligence (AI).

In addition, Biotricity started to build its sales force and expanded pilot sites to hasten market entry. Moreover, the Company received ethics approval to investigate mobile wireless fetal monitoring. Biotricity’s objectives for this year include launching Bioflux 1.0 by the end of Q2, with first revenues expected in early Q3. Its objectives also include commencing clinical benchmarking of device level AI in Q3, as well as deploying cloud-based AI for Bioflux 1.0 in Q3.

Furthermore, its objectives include completing Bioflux 2.0 development and prototyping, and filing 510(k) application with the FDA by the end of Q4. Biotricity anticipates development of Biolife by the end of Q3 with prototypes available by the end of Q4.

Also, Company objectives include testing and prototyping its next remote patient monitoring solutions. More details of this will be announced in Q3. The Company also aims to list on a National Exchange.

Last week, Biotricity announced that the San Antonio Endovascular & Heart Institute (SAEHi) deployed Biotricity’s Bioflux on April 6, 2018. SAEHi will take advantage of the real-time, high-precision mobile cardiac telemetry solution to help in the diagnosis of cardiac arrhythmias, enhance patient outcomes, improve patient compliance, as well as control healthcare costs. SAEHi is a practice specializing in diagnosing, treating, managing, and researching diseases and disorders of the heart and vascular system.

Biotricity, Inc. (BTCY), closed Monday's trading session at $4.55, up 6.06%, on 42,897 volume with 77 trades. The average volume for the last 60 days is 48,398 and the stock's 52-week low/high is $1.81/$19.50.


The QualityStocks Company Corner

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares, covering sections of 13 salars or mineral salt flats and one laguna complex.

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.695, even for the day. The average volume for the last 60 days is 1,888 and the stock's 52-week low/high is $0.6599/$0.9021.

Recent News


Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH).

Software development and mobile solutions company Consorteum Holdings’ (OTC: CSRH) wholly owned subsidiary 359 Mobile Inc. is focused on the development of end-to-end fintech solutions for various markets. To view the full article, visit:

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

Consorteum Holdings, Inc. (CSRH), closed the day's trading session at $0.0026, up 54.76%, on 27,798,874 volume with 195 trades. The average volume for the last 60 days is 8,283,627 and the stock's 52-week low/high is $0.0005/$0.0085.

Recent News



The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

EVIO Inc. (OTCQB:EVIO) (“EVIO” or “the Company”) a leading provider of cannabis testing and scientific research for the regulated cannabis industry, is pleased to announce that it has executed an asset purchase agreement to acquire 100% of California-based testing lab, Leaf Detective, LLC. Also today, EVIO announced that company CEO, William Waldrop, joined Everett Jolly in first Uptick Newswire’s “Stock Day” podcast. To listen to the full interview please click here to the following link:

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.63, up 12.41%, on 98,153 volume with 155 trades. The average volume for the last 60 days is 78,813 and the stock's 52-week low/high is $0.47/$2.70.

Recent News


Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is forging new roads in the oil and gas space with its patented heavy oil processing and extraction technologies. The company recently announced expansion progress at its Asphalt Ridge heavy oil extraction facility, which is located near Vernal, Utah, and which will implement the company’s proprietary extraction technology in converting Utah’s oil-rich resources into energy (

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $0.711, up 4.56%, on 34,902 volume with 54 trades. The average volume for the last 60 days is 150,339 and the stock's 52-week low/high is $0.0218/$1.8892.

Recent News


AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF).

Artificial intelligence (“AI”) company AnalytixInsight (TSX.V: ALY) (OTCQB: ATIXF) has developed technology that has vast applications across multiple industries. To view the full article, visit:

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company’s flagship product – – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube’s online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube’s freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy’s largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo’s 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo’s established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners.

AnalytixInsight Inc. (ATIXF), closed the day's trading session at $0.3122, up 1.00%, on 1,000 volume with 1 trades. The average volume for the last 60 days is 7,915 and the stock's 52-week low/high is $0.15/$0.6898.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX). Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces new cryptocurrency and trading courses offered through its newly established Bitcoin Trading Academy LLC beginning in June 2018.

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.546, up 0.37%, on 43,238 volume with 24 trades. The average volume for the last 60 days is 56,013 and the stock's 52-week low/high is $0.40/$1.58.

Recent News


Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF)

The QualityStocks Daily Newsletter would like to spotlight Global Hemp Group, Inc. (GBHPF).

While states continue to grapple with how they will approach medical and recreational marijuana controversies, as well as the federal government’s drug classification policy in the United States, a more cooperative camaraderie appears to be developing nationwide in regard to the growth of industrial hemp, the cannabis plant’s non-psychoactive breed. Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) has long had an interest in establishing a strong footing in the industrial hemp industries of Canada and the United States.

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTCQB: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant. Global Hemp Group’s focused on attracting joint venture partners across all sectors of the industrial hemp industries with the commitment to improve quality of life by researching, developing and distributing sustainable materials, products and services produced from hemp.

The company’s mission is to build a strategic portfolio of hemp-based companies that operate synergistically to consistently deliver a solid ROI to its shareholders. Global Hemp Group has established the concept of Hemp Agro-Industrial Zone (HAIZ) ( in order to build cooperative mechanisms across industrial sectors with a focus on different parts of the hemp plant. Under the HAIZ strategy, Global Hemp Group brings together capital, farmers and labor in an effort to build a “soil-to-shelf” portfolio of complimentary companies and joint venture partners in the global hemp industry.

Global Hemp Group has chosen to only work with suppliers of high quality, sustainable raw materials and finished products derived from the hemp plant. Among the leading industries utilizing industrial hemp’s exceptional properties is the automotive sector, building materials market, bio-composites, energy-related markets, super-foods, nutritional supplements, nutraceuticals and the cannabinoid markets. Guided by the principal theme of “global environmental stewardship,” Global Hemp Group focuses on the key concepts of sustainability and social responsibility in all its endeavors.

Global Hemp Group’s joint venture with publicly traded Marijuana Company of America on hemp cultivation trials in 2017, designed to develop commercial hemp production on the Acadian peninsula of New Brunswick, Canada, for the first time in 20 years, was a great success. The partners are preparing for the upcoming changes in Canada’s cannabis legislation that will permit cannabinoid extraction from industrial hemp. Farmers have already been recruited to plant a minimum of 125 acres of industrial hemp for the 2018 growing season, with the goal of increasing the acreage under cultivation to 1,000+ acres by year three of the joint project. Global Hemp Group is preparing an application for a processing license to extract cannabidiol (CBD) and other cannabinoids from the upcoming industrial hemp crop. Discussions are also underway with potential processing partners for the extraction of cannabinoids and straw processing for building materials for the upcoming harvest in October 2018, with a longer term plan to establish permanent processing facilities by October 2019.

Global Hemp Group is led by Charles Larsen as its president, CEO and chairman of the board. Larsen’s more than 30 years of experience working in government, public, private and startup companies as an executive manager includes being the founding president of Medical Marijuana, Inc., the first public company in the Cannabis space. Larsen is also a founder and current director of Marijuana Company of America, Inc., and has been actively involved in the cannabis and hemp industry for nearly a decade. Larsen is joined by Curt Huber, who serves as CFO and director. Huber is an independent corporate and financial consultant with more than 25 years of experience in all facets of public companies among many different sectors including mining, oil and gas, and technology.

Also joining the management team as director is Dr. Paul T. Perrault, an agricultural economist trained in cooperative development and in rural development. Perrault’s experience includes years of consulting on rural development projects introducing new crops in several developing countries and strengthening agricultural research organizations, principally in Africa. Jeff Kilpatrick also serves as a director and is currently a program supervisor of Alachua County Department of Court Services in Gainesville, Florida. Kilpatrick, who spent 21 years in the U.S. Coast Guard, is a member of LEAP – Law Enforcement Against Prohibition – and is president elect for the National Association of Pretrial Services Agencies (NAPSA).

Global Hemp Group’s business philosophy is “A healthier future through sustainable business strategies.“

Global Hemp Group, Inc. (GBHPF), closed the day's trading session at $0.10, even for the day, on 57,070 volume with 30 trades. The average volume for the last 60 days is 162,506 and the stock's 52-week low/high is $0.0115/$0.316.

Recent News


First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced First Cobalt Corp (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF), a cobalt exploration and development company, has qualified to trade on the OTCQX® Best Market. First Cobalt upgraded to OTCQX from the OTCQB® Venture Market.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.596, up 1.02%, on 98,332 volume with 69 trades. The average volume for the last 60 days is 162,016 and the stock's 52-week low/high is $0.3148/$1.3041.

Recent News


Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Currently at the strongest financial position in its history after a highly successful 2017, global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) is moving forward with its goal of simplifying global commerce and payments through proprietary multi-channel platform Netevia (

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $7.93, off by 0.63%, on 172,977 volume with 791 trades. The average volume for the last 60 days is 971,370 and the stock's 52-week low/high is $2.556/$33.51.

Recent News


Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Canadian Cannabis Presents Opportunities in Cultivation and Retail," featuring Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF). To hear the NetworkNewsAudio version, visit To read the original editorial, visit

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.675, off by 3.30%, on 224,455 volume with 230 trades. The average volume for the last 60 days is 134,866 and the stock's 52-week low/high is $0.125/$0.8612.

Recent News


Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

Through its joint venture ownership of MIDS Medical Limited (MML) (, located at the United Kingdom’s prestigious Sci-Tech Daresbury campus, Zenosense, Inc. (OTC: ZENO) is developing MIDS Cardiac™. This handheld device aims to deliver accuracy equal or superior to these ‘gold standard’ central laboratory analyzers at the POC – taking lab testing to the patient. MIDS Cardiac aims to deliver high sensitivity results that are available within minutes.

Zenosense, Inc. (ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed the day's trading session at $0.41, off by 2.38%, on 164,482 volume with 55 trades. The average volume for the last 60 days is 101,392 and the stock's 52-week low/high is $0.2021/$0.895.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.